Search for: "Bristol Myers Squibb"
Results 681 - 700
of 866
Sorted by Relevance
|
Sort by Date
7 Jan 2016, 1:37 pm
From the this December 23, 2015 Reuters news report, "New blood thinner 'antidote' to help doctors move past warfarin", we get some insight about this current "no antidote" situation: Xarelto, from Bayer AG and Johnson & Johnson, and Eliquis, sold by Bristol-Myers Squibb and Pfizer, were approved as safer and more convenient alternatives for preventing blood clots and strokes than warfarin. [read post]
18 Aug 2010, 12:19 am
(IP Whiteboard) Australia: A tale of four amendment requests: Bristol-Myers Squibb Company v. [read post]
8 Aug 2006, 3:05 pm
Bristol- Myers Squibb Co. v. [read post]
19 Mar 2012, 6:20 am
Norman gives a lucid account of Judge Birss QC's summary of principles relevant to the grant or refusal of interim injunctive relief, in a hearty tussle between Bristol-Myers Squibb and Teva over the prospect of the latter launching a generic version of efavirenz. [read post]
24 Oct 2017, 7:00 am
Out-of-State Restrictions In a case involving Bristol-Myers Squibb, the Missouri Supreme Court ruled in June 2017 that courts only have jurisdiction over an out-of-state claim if there exists an “affiliation between the forum and the underlying controversy, principally, [an] activity or an occurrence that takes place in the forum State. [read post]
28 Nov 2016, 3:52 am
Abilify’s History Approved by the FDA in 2002, Abilify, which comes in many forms, including a tablet, liquid or an injection (including an extended-release injection), is manufactured by Bristol-Myers Squibb and the Otsuka America Pharmaceutical, and has consistently topped 5 billion dollars in yearly sales. [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) – US:… [read post]
9 Jul 2015, 3:28 pm
Xarelto, has grabbed a 32 percent market share in the highly competitive anticoagulant market, significantly ahead of Boehringer’s Pradaxa and Bristol-Myers Squibb’s Eliquis, the other two new anticoagulants in the market. [read post]
28 Jun 2017, 8:34 am
Ability’s manufacturers, Otsuka and Bristol-Myers Squibb, are facing a growing number of lawsuits from patients who claim they couldn’t control the urge to gamble or over-eat, or that they developed hyper sexual behaviors. [read post]
23 Oct 2008, 10:18 am
The Wall Street Journal writes, During his five years as chief executive of Bristol-Myers Squibb ...peterrost.blogspot.com/2006/08/bye-bye-peter-dolan-hello-karen-katen.html - 67k - Cached - Similar pages - Note thisTHE PETER ROST BLOG: Pfizer CEO eliminates Karen Katen executivesJan 23, 2007 ... [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the… [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
20 Aug 2024, 1:25 pm
In a 2-1 decision reversing the lower court, the Seventh Circuit last week joined the Third, Sixth, and Eighth circuits in holding that the Supreme Court’s 2017 decision in Bristol-Myers Squibb Co. v. [read post]
22 Oct 2018, 8:17 pm
Bristol-Myers Squibb Co., et al. v. [read post]
12 Dec 2014, 10:29 pm
See Bristol-Myers Squibb Co. v. [read post]
10 Jun 2009, 10:00 pm
Bristol-Myers Squibb, 1998 WL 812318, at 30 (M.D. [read post]
7 Jul 2021, 11:44 pm
The Patentees filed two PTE applications, each of which was based on different goods on the ARTG: Brand Name OPDIVO® KEYTRUDA® Active ingredient nivolumab pembrolizumab Australian sponsor Bristol-Myers Squibb Australia Pty Ltd Merck Sharp & Dohme (Australia) Pty Ltd Relationship between sponsor and patentees Related to one of the patentees Not related to either patentee Date goods containing the drug were first included on ARTG 11 January 2016 16 April 2015… [read post]
18 Feb 2011, 11:47 am
., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
23 Apr 2012, 3:33 am
It also noted that Philipson’s research was supported in part by Bristol-Myers Squibb Co. [read post]
19 Mar 2010, 1:22 am
Solomon, who co-chaired Proskauer's litigation practice until last year, will bring with him a roster of clients, including PepsiCo, Bristol-Myers Squibb and AriZona Iced Tea. [read post]
